亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北恒綠源化工有限公司  

氟比洛芬,醋氯芬酸,雙氯芬酸二乙胺鹽

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:高潔
  • 電話:027-88188016
  • 郵件:1764683941@qq.com
  • 傳真:027-88188026
  • QQ:1764683941
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 替硝唑
替硝唑
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
品牌 替硝唑
型號 替硝唑
規格 替硝唑
過期 長期有效
更新 2019-10-30 15:14
 
詳細信息
替硝唑2-甲基-1-[2-(乙基磺酰基)乙基]-5-硝基-1H-咪唑 
英文名稱: tinidazole
英文別名: Diamicron; Dramion; Nordialex; 1-[2-(ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole
CAS號: 19387-91-8
EINECS號: 243-014-4
分子式: C8H13N3O4S
分子量: 247.2715 
InChI: InChI=1/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3 
密度: 1.43g/cm3 
沸點: 528.4°C at 760 mmHg 
閃點: 273.4°C 
蒸汽壓: 1E-10mmHg at 25°C 
 物化性質:
無色結晶。
©2025 湖北恒綠源化工有限公司 版權所有   技術支持:化工網   訪問量:16596  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |